Yamashita et al., 1999 - Google Patents
A case of natural killer/T cell lymphoma of the subcutis resembling subcutaneous panniculitis‐like T cell lymphomaYamashita et al., 1999
- Document ID
- 7477715989379827474
- Author
- Yamashita Y
- Tsuzuki T
- Nakayama A
- Fujino M
- Mori N
- Publication year
- Publication venue
- Pathology international
External Links
Snippet
A case of nasal type natural killer (NK)/T cell lymphoma of the subcutis showing clinical and morphological features that resemble subcutaneous panniculitis‐like T cell lymphoma (SPTCL) is presented. A 73‐year‐old man presented with swelling of the left arm and was …
- 206010042971 T-cell lymphoma 0 title abstract description 21
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/574—Immunoassay; Biospecific binding assay for cancer
- G01N33/57407—Specifically defined cancers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Gaal et al. | Sinonasal NK/T-cell lymphomas in the United States | |
Slamon et al. | Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer | |
Warnke | Tumors of the lymph nodes and spleen | |
Khoury et al. | CD56+ TdT+ blastic natural killer cell tumor of the skin: a primitive systemic malignancy related to myelomonocytic leukemia | |
de Leval et al. | Diffuse large B-cell lymphoma of Waldeyer's ring has distinct clinicopathologic features: a GELA study | |
Florian et al. | Indolent systemic mastocytosis with elevated serum tryptase, absence of skin lesions, and recurrent severe anaphylactoid episodes | |
Leng‐Kit Lei et al. | Aggressive primary hepatic lymphoma in Chinese patients. Presentation, pathologic features, and outcome | |
Boulland et al. | Cytotoxic protein expression in natural killer cell lymphomas and in αβ and γδ peripheral T‐cell lymphomas | |
Terasaki et al. | Eosinophilic infiltration of the liver in primary biliary cirrhosis: a morphological study | |
Yamashita et al. | A case of natural killer/T cell lymphoma of the subcutis resembling subcutaneous panniculitis‐like T cell lymphoma | |
Karube et al. | The expression of CD30 and its clinico-pathologic significance in peripheral T-cell lymphomas | |
Shimada et al. | Current progress and future perspectives of research on intravascular large B‐cell lymphoma | |
Sawa et al. | In vitro induction of activation-induced cell death in lymphocytes from chronic periodontal lesions by exogenous Fas ligand | |
Karube et al. | Non-B, non-T neoplasms with lymphoblast morphology: further clarification and classification | |
EP3200807A1 (en) | Analysis of t-cell monotypia | |
Sotto et al. | Antigen distribution and antigen‐presenting cells in skin biopsies of human chromoblastomycosis | |
Hasegawa et al. | Adult neuroblastoma of the retroperitoneum and abdomen: clinicopathologic distinction from primitive neuroectodermal tumor | |
McLELLAND et al. | A flow cytometric study of Langerhans cell histiocytosis | |
DiCaudo et al. | Clinical and histologic spectrum of human T-cell lymphotropic virus type I—associated lymphoma involving the skin | |
Inaba et al. | Expression of T‐cell‐associated antigens in B‐cell non‐Hodgkin's lymphoma | |
Kitamura et al. | Primary lymphoma arising in the nasal cavity among Japanese | |
Pentheroudakis et al. | The neutrophil, not the tumor: Serum CA 15‐3 elevation as a result of granulocyte—Colony‐stimulating factor–induced neutrophil MUC1 overexpression and neutrophilia in patients with breast carcinoma receiving adjuvant chemotherapy | |
Saleh et al. | High prevalence of hepatitis C virus among B-cell non Hodgkin lymphoma patients in Mansoura Region (Egypt), ANRS 12263 Study | |
Hanitsch et al. | Portal hypertension in common variable immunodeficiency disorders–a single center analysis on clinical and immunological parameter in 196 patients | |
Kagami et al. | A nodal γ/δ T-cell lymphoma with an association of Epstein-Barr virus |